PetIQ, Inc. (NASDAQ:PETQ) Shares Sold by Calamos Advisors LLC

Calamos Advisors LLC lessened its holdings in shares of PetIQ, Inc. (NASDAQ:PETQ) by 43.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 59,986 shares of the company’s stock after selling 45,940 shares during the period. Calamos Advisors LLC’s holdings in PetIQ were worth $1,185,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in shares of PetIQ by 13.4% in the third quarter. Vanguard Group Inc. now owns 1,918,500 shares of the company’s stock worth $37,794,000 after buying an additional 226,718 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in shares of PetIQ by 13.8% during the third quarter. Assenagon Asset Management S.A. now owns 416,878 shares of the company’s stock worth $8,212,000 after purchasing an additional 50,647 shares during the last quarter. DekaBank Deutsche Girozentrale acquired a new position in PetIQ in the fourth quarter worth about $50,000. Acadian Asset Management LLC increased its holdings in PetIQ by 124.5% in the third quarter. Acadian Asset Management LLC now owns 38,600 shares of the company’s stock valued at $759,000 after buying an additional 21,409 shares during the last quarter. Finally, Barclays PLC raised its stake in PetIQ by 55.4% during the third quarter. Barclays PLC now owns 22,917 shares of the company’s stock valued at $451,000 after buying an additional 8,173 shares in the last quarter. 94.99% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group raised their price objective on PetIQ from $24.00 to $28.00 and gave the stock a “buy” rating in a research note on Tuesday, March 19th. Four analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $29.00.

PetIQ Stock Performance

Shares of PETQ opened at $16.28 on Monday. The company has a debt-to-equity ratio of 1.97, a current ratio of 2.27 and a quick ratio of 1.43. The firm’s 50 day moving average is $17.45 and its 200-day moving average is $18.34. PetIQ, Inc. has a 12-month low of $11.26 and a 12-month high of $22.98. The stock has a market capitalization of $479.12 million, a P/E ratio of 271.38 and a beta of 1.64.

PetIQ (NASDAQ:PETQ) last released its quarterly earnings data on Wednesday, February 28th. The company reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.38) by $0.22. The business had revenue of $219.93 million during the quarter, compared to analyst estimates of $189.70 million. PetIQ had a return on equity of 11.72% and a net margin of 0.19%. Equities research analysts anticipate that PetIQ, Inc. will post 0.94 EPS for the current fiscal year.

PetIQ Company Profile

PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.